The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils

Journal of Lipid Research

Volumn 53, Issue 3, 2012, Pages 390-398

  Petrlova, Jitka ^a   Duong, Trang ^c   Cochran, Megan C ^c   Axelsson, Annika ^a   Mörgelin, Matthias ^b   Roberts, Linda M ^c   Lagerstedt, Jens O ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Amyloid; ApoA I; Fibril formation; High density lipoprotein; Protein stability

Indexed keywords

APOLIPOPROTEIN A1; ARGININE; GUANINE; HISTIDINE; LEUCINE; PROTEIN VARIANT;

ARTICLE; CONTROLLED STUDY; FIBER; HUMAN; INCUBATION TIME; LIPID STORAGE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LIPID INTERACTION; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; TISSUE SPECIFICITY; WILD TYPE;

APOLIPOPROTEIN A-I; CIRCULAR DICHROISM; HUMANS; KIDNEY; LIPOPROTEINS, HDL; LIVER; MICROSCOPY, ELECTRON; MUTATION; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY;

EID: 84857745587     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M020883     Document Type: Article

References (40)

1. Tardif, J. C. 2010. Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology? J. Clin. Lipidol. 4: 399-404.
2. Westermark, P., G. Mucchiano, T. Marthin, K. H. Johnson, and K. Sletten. 1995. Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am. J. Pathol. 147: 1186-1192.
3. Bagnato, C., J. Thumar, V. Mayya, S. I. Hwang, H. Zebroski, K. P. Claffey, C. Haudenschild, J. K. Eng, D. H. Lundgren, and D. K. Han. 2007. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics. 6: 1088-1102. (Pubitemid 47019409)
4. Lepedda, A. J., A. Cigliano, G. M. Cherchi, R. Spirito, M. Maggioni, F. Carta, F. Turrini, C. Edelstein, A. M. Scanu, and M. Formato. 2009. A proteomic approach to differentiate histologically classifi ed stable and unstable plaques from human carotid arteries. Atherosclerosis. 203: 112-118.
5. Andreola, A., V. Bellotti, S. Giorgetti, P. Mangione, L. Obici, M. Stoppini, J. Torres, E. Monzani, G. Merlini, and M. Sunde. 2003. Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I. J. Biol. Chem. 278: 2444-2451. (Pubitemid 36801320)
6. Lagerstedt, J. O., G. Cavigiolio, L. M. Roberts, H. S. Hong, L. W. Jin, P. G. Fitzgerald, M. N. Oda, and J. C. Voss. 2007. Mapping the structural transition in an amyloidogenic apolipoprotein A-I. Biochemistry. 46: 9693-9699. (Pubitemid 47328575)
7. de Sousa, M. M., C. Vital, D. Ostler, R. Fernandes, J. Pouget-Abadie, D. Carles, and M. J. Saraiva. 2000. Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis. Am. J. Pathol. 156: 1911-1917. (Pubitemid 30641760)
8. Hazenberg, A. J., F. G. Dikkers, P. N. Hawkins, J. Bijzet, D. Rowczenio, J. Gilbertson, M. D. Posthumus, M. K. Leijsma, and B. P. Hazenberg. 2009. Laryngeal presentation of systemic apolipoprotein A-I-derived amyloidosis. Laryngoscope. 119: 608-615.
9. Ryan, R. O., T. M. Forte, and M. N. Oda. 2003. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr. Purif. 27: 98-103. (Pubitemid 37096475)
10. Lagerstedt, J. O., M. S. Budamagunta, M. N. Oda, and J. C. Voss. 2007. Electron paramagnetic resonance spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apoA-I in solution. J. Biol. Chem. 282: 9143-9149. (Pubitemid 47093480)
11. Morrow, J. A., M. L. Segall, S. Lund-Katz, M. C. Phillips, M. Knapp, B. Rupp, and K. H. Weisgraber. 2000. Differences in stability among the human apolipoprotein E isoforms determined by the aminoterminal domain. Biochemistry. 39: 11657-11666.
12. Koyama, M., M. Tanaka, P. Dhanasekaran, S. Lund-Katz, M. C. Phillips, and H. Saito. 2009. Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I. Biochemistry. 48: 2529-2537.
13. Pastukhov, A. V., and I. J. Ropson. 2003. Fluorescent dyes as probes to study lipid-binding proteins. Proteins. 53: 607-615. (Pubitemid 37352174)
14. Ji, Y., and A. Jonas. 1995. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins. J. Biol. Chem. 270: 11290-11297.
15. Roberts, L. M., M. J. Ray, T. W. Shih, E. Hayden, M. M. Reader, and C. G. Brouillette. 1997. Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I. Biochemistry. 36: 7615-7624. (Pubitemid 27262389)
16. Engel, J., and H. Furthmayr. 1987. Electron microscopy and other physical methods for the characterization of extracellular matrix components: laminin, fibronectin, collagen IV, collagen VI, and proteoglycans. Methods Enzymol. 145: 3-78. (Pubitemid 19059239)
17. Panagotopulos, S. E., S. R. Witting, E. M. Horace, D. Y. Hui, J. N. Maiorano, and W. S. Davidson. 2002. The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATPbinding cassette transporter ABCA1. J. Biol. Chem. 277: 39477-39484. (Pubitemid 35190924)
18. Jayaraman, S., S. Abe-Dohmae, S. Yokoyama, and G. Cavigiolio. 2011. Impact of self-association on function of apolipoprotein A-I. J. Biol. Chem. 286: 35610-35623.
19. Brubaker, G., D. Q. Peng, B. Somerlot, D. J. Abdollahian, and J. D. Smith. 2006. Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity. Biochim. Biophys. Acta. 1761: 64-72.
20. Silva, R. A., G. M. Hilliard, J. Fang, S. Macha, and W. S. Davidson. 2005. A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry. 44: 2759-2769. (Pubitemid 40293652)
21. Zannis, V. I., A. Chroni, and M. Krieger. 2006. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J. Mol. Med. (Berl). 84: 276-294.
22. Hatters, D. M., N. Zhong, E. Rutenber, and K. H. Weisgraber. 2006. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils. J. Mol. Biol. 361: 932-944. (Pubitemid 44189440)
23. Kirkitadze, M. D., M. M. Condron, and D. B. Teplow. 2001. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J. Mol. Biol. 312: 1103-1119. (Pubitemid 32980329)
24. Abedini, A., and D. P. Raleigh. 2009. A role for helical intermediates in amyloid formation by natively unfolded polypeptides? Phys. Biol. 6: 015005.
25. Lazar, K. L., H. Miller-Auer, G. S. Getz, J. P. Orgel, and S. C. Meredith. 2005. Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure. Biochemistry. 44: 12681-12689. (Pubitemid 41377308)
26. Di Gaetano, S., F. Guglielmi, A. Arciello, P. Mangione, M. Monti, D. Pagnozzi, S. Raimondi, S. Giorgetti, S. Orru, C. Canale, et al. 2006. Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential. Biochem. Biophys. Res. Commun. 351: 223-228. (Pubitemid 44637274)
27. Monti, D. M., F. Guglielmi, M. Monti, F. Cozzolino, S. Torrassa, A. Relini, P. Pucci, A. Arciello, and R. Piccoli. 2010. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation. Eur. Biophys. J. 39: 1289-1299.
28. Mangione, P., M. Sunde, S. Giorgetti, M. Stoppini, G. Esposito, L. Gianelli, L. Obici, L. Asti, A. Andreola, P. Viglino, et al. 2001. Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. Protein Sci. 10: 187-199. (Pubitemid 32221176)
29. Anantharamaiah, G. M., J. L. Jones, C. G. Brouillette, C. F. Schmidt, B. H. Chung, T. A. Hughes, A. S. Bhown, and J. P. Segrest. 1985. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J. Biol. Chem. 260: 10248-10255. (Pubitemid 16246560)
30. Rogers, D. P., L. M. Roberts, J. Lebowitz, J. A. Engler, and C. G. Brouillette. 1998. Structural analysis of apolipoprotein A-I: effects of amino- and carboxy-terminal deletions on the lipid-free structure. Biochemistry. 37: 945-955. (Pubitemid 28060476)
31. Mei, X., and D. Atkinson. 2011. Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization. J. Biol. Chem. 286: 38570-38582.
32. Obici, L., G. Franceschini, L. Calabresi, S. Giorgetti, M. Stoppini, G. Merlini, and V. Bellotti. 2006. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid. 13: 191-205. (Pubitemid 44764459)
33. Sousa, M. M., L. Berglund, and M. J. Saraiva. 2000. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J. Lipid Res. 41: 58-65. (Pubitemid 30051842)
34. Liz, M. A., C. J. Faro, M. J. Saraiva, and M. M. Sousa. 2004. Transthyretin, a new cryptic protease. J. Biol. Chem. 279: 21431-21438. (Pubitemid 38656553)
35. Liz, M. A., C. M. Gomes, M. J. Saraiva, and M. M. Sousa. 2007. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J. Lipid Res. 48: 2385-2395. (Pubitemid 350058750)
36. Westermark, P., K. Sletten, B. Johansson, and G. G. Cornwell 3rd. 1990. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA. 87: 2843-2845.
37. Rogers, D. P., L. M. Roberts, J. Lebowitz, G. Datta, G. M. Anantharamaiah, J. A. Engler, and C. G. Brouillette. 1998. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry. 37: 11714-11725. (Pubitemid 28400043)
38. Alexander, E. T., M. Tanaka, M. Kono, H. Saito, D. J. Rader, and M. C. Phillips. 2009. Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I. J. Lipid Res. 50: 1409-1419.
39. Tanaka, M., P. Dhanasekaran, D. Nguyen, M. Nickel, Y. Takechi, S. Lund-Katz, M. C. Phillips, and H. Saito. 2011. Influence of N-terminal helix bundle stability on the lipid-binding properties of human apolipoprotein A-I. Biochim. Biophys. Acta. 1811: 25-30.
40. Lagerstedt, J. O., M. S. Budamagunta, G. S. Liu, N. C. DeValle, J. C. Voss, and M. N. Oda. 2011. The "Beta-Clasp" model of apolipoprotein A-I-a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy. Biochim. Biophys. Acta. In press.